Results 91 to 100 of about 5,253,337 (215)

Critical appraisal of a quadrivalent CRM197 conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo®) in the context of treatment and prevention of invasive disease

Infection and Drug Resistance, 2011
Michael Bröker, Brian Cooper, Lisa M DeTora, Jeffrey J StoddardGlobal Medical Affairs, Novartis Vaccines and Diagnostics, Marburg, Germany, and Cambridge, MA, USAAbstract: Worldwide, invasive meningococcal disease affects about 500,000 people ...
Bröker M, Cooper B, DeTora LM, Stoddard JJ   +3 more
doaj  

Infectious diseases: meningococcal disease

Western Journal of Medicine, 2000
This article comes from Clinical Evidence (2000;3:350-357), a new resource for clinicians produced jointly by the BMJ Publishing Group and theAmerican College of Physicians—American Society of Internal Medicine.Clinical Evidence is an extensively peer-reviewed publication that summarizes the best available evidence on the effects of common clinical ...
openaire   +3 more sources

Meningococcal ACWY vaccine [PDF]

Meningococcal disease is a serious illness caused by a type of bacteria called Neisseria meningitidis. It can lead to meningitis (infection of the lining of the brain and spinal cord) and infections of the blood.

core  

Current safety issues with quadrivalent meningococcal conjugate vaccines

Human Vaccines & Immunotherapeutics, 2018
Invasive meningococcal disease, although rare, can present as sudden, life-threatening disease with high risk of mortality or severe long-term sequelae.
Tanya R. Myers, Michael M. McNeil
doaj   +1 more source

Herpesviruses, as a possible cause complicated course of invasive meningococcal disease (clinical case)

Журнал инфектологии, 2016
The article describes the clinical case of meningococcal infections, complicated with the development of reactive arthritis. It highlights possible pathogenetic mechanisms of aseptic inflammation in combined meningococcal and herpesvirus infections.
N. V. Skripchenko, A. A. Vilnits, A. S. Drap, I. A. Ivashchenko   +3 more
doaj  

Meningococcal vaccines session [PDF]

Meningococcal-1-Stephens-508 ...

core   +2 more sources

Development of MenFive®, an affordable pentavalent meningococcal conjugate vaccine (ACYWX) for Africa and beyond

Human Vaccines & Immunotherapeutics
Wide use of the groundbreaking vaccine MenAfriVac® has eliminated serogroup A meningococcal meningitis in the African meningitis belt and paved the way for elimination of all meningococcal disease outbreaks with the development, licensure, and ...
Mark R. Alderson, Katie Regan, Lionel Martellet, Nancy Hosken, Prasad S. Kulkarni, Sambhaji S. Pisal, F. Marc LaForce, Rajeev M. Dhere   +7 more
doaj   +1 more source

Meningococcal vaccines

, 2017
Meningococcal disease is caused by the bacterium Neisseria meningitides. Meningococcal disease most often presents as meningitis, blood poisoning and pneumonia. (See fact sheet available at https://www.nt.gov.au and search for meningococcal.

core  

Meningococcal ACWY vaccine poster

, 2018
Poster to promote the Meningococcal ACWY vaccine ...

core  

Meningococcal Disease Surveillance

Rates of meningococcal disease in the United States increased in 2023. Public health officials track all meningococcal disease in the United States.

core